(Q41743831)
Statements
1 reference
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. (English)
1 reference
L Bergmann
1 reference
L Maute
1 reference
G Heil
1 reference
J Rüssel
1 reference
E Weidmann
1 reference
D Köberle
1 reference
S Fuxius
1 reference
K Weigang-Köhler
1 reference
W E Aulitzky
1 reference
B Wörmann
1 reference
G Hartung
1 reference
B Moritz
1 reference
L Edler
1 reference
I Burkholder
1 reference
M E Scheulen
1 reference
H Richly
1 reference
5 November 2014
1 reference
1 reference
Identifiers
1 reference